Active Ingredient: ACETAMINOPHEN
Proprietary Name: ACETAMINOPHEN
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 1GM/100ML (10MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N206968
Product Number: 001
Approval Date: Jun 3, 2022
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information